全球粘液纤毛清除和功能障碍治疗市场 – 行业趋势和 2029 年预测

全球粘液纤毛清除和功能障碍治疗市场分析和见解

慢性阻塞性肺病和其他呼吸道疾病的负担越来越重，进一步导致粘膜纤毛功能障碍，推动了全球市场的增长。粘膜纤毛清除的有效治疗方法的采用率增加，导致预测期内市场大幅增长。此外，呼吸道疾病的持续激增预计将导致未来几年粘膜纤毛清除和功能障碍治疗市场以显著的速度增长。

• Data Bridge Market Research 分析称，2021 年粘液纤毛清除和功能障碍治疗市场价值为 6.02 亿美元，预计到 2029 年将达到 9.6676 亿美元，在 2022-2029 年预测期内的复合年增长率为 6.10%。在预测期内，“医院”占粘液纤毛清除和功能障碍治疗市场中最大的终端用户部分。

全球粘液纤毛清除和功能障碍治疗市场定义

黏液纤毛功能障碍是慢性阻塞性肺病的常见症状。黏液纤毛清除是众所周知的先天防御系统，可抵御通过鼻腔吸入的微生物和刺激物。鼻窦系统中的糖精测试可用于评估黏液纤毛清除。黏液纤毛清除的治疗通常包括使用蛋白水解酶降低黏液粘度、使用振动改善纤毛摆动频率、使用 Locke-Ringer 溶液冲洗以改善纤毛频率、使用糖类固醇和表面活性剂。

粘液纤毛清除及功能障碍治疗 市场动态

驱动程序

• 呼吸系统疾病病例不断增加 

全球范围内的慢性阻塞性肺病（COPD）、哮喘等呼吸系统疾病将导致治疗市场增长率的扩大。

Moreover, the adoption of unhealthy lifestyle and rising number of vaccines in pipeline are also the growth determinants that bolster the market's growth. Also, the developments in healthcare technology will further enhance the growth of mucociliary clearance and dysfunction treatment market. Furthermore, the rising initiatives to spread awareness regarding the respiratory disease is the factor that will expand the mucociliary clearance and dysfunction treatment market. The new therapies and treatment for management of mucociliary clearance will positively impact the mucociliary clearance and dysfunction treatment market's growth rate.

Opportunities

Moreover, the advancements in technology and availability of new therapies and medical devices for treatment will boost new opportunities for the market's growth rate. Also, the increased awareness regarding the treatment and ongoing clinical trials will escalate the growth rate mucociliary clearance and dysfunction treatment market in future.

Restraints/Challenges Global Mucociliary Clearance and Dysfunction Treatment Market

However, the low awareness about the available treatment will impede the growth rate of mucociliary clearance and dysfunction treatment market. Additionally, the lack in research and development in the related field is projected to hamper market growth.

This mucociliary clearance and dysfunction treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on mucociliary clearance and dysfunction treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The mucociliary dysfunction is a common sign of chronic obstructive pulmonary disease. Chronic airway mucus hypersecretion can cause COPD patients' pulmonary function to deteriorate over time. According to research, COPD was found to be prevalent in 3.6 percent of our adult population (aged 45 years) and increased dramatically with age (1.9 percent in 45–64 years, 4.8 percent in 65–74 years, 6.8 percent in 75–84 years, and 5.6 percent in 85 years).

Mucociliary clearance and dysfunction treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Mucociliary Clearance and Dysfunction Treatment Market

Healthcare and pharmaceutical industries were heavily impacted by the COVID-19. However, the mucociliary clearance and dysfunction treatment market was affected largely by the sudden emergence of the COVID-19. The isolation regulations across the globe further disrupted the supply chain and even caused delays in the import and export of drugs and medicines for the mucociliary clearance causing a negative impact on the market. On the flip side, the people suffering from various respiratory diseases such as COPD and interstitial lung disease had high chances of contracting coronavirus, which causes mucociliary dysfunction and increases the demand for mucociliary clearance and dysfunction treatment, resulting in a higher demand in increase in the growth of the market.

Recent Developments

• In July 2021, The US Food and Drug Administration has accepted AstraZeneca's Biologics License Application (BLA) for tezepelumab and granted it Priority Review for the treatment of asthma (FDA). AstraZeneca Plc is developing Tezepelumab in collaboration with Amgen Inc.

Global Mucociliary Clearance and Dysfunction Treatment Market Scope

The mucociliary clearance and dysfunction treatment market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Medications
• Surgery
• Mucus Clearance Device
• Others

On the basis of treatment, mucociliary clearance and dysfunction treatment market is segmented into medications, surgery, mucus clearance device and others. Medications can be further segmented into expectorants, mucoregulators, mucolytics and others.

Route of Administration

• Oral
• Inhalation
• Others

On the basis of route of administration, the mucociliary clearance and dysfunction treatment market is segmented into oral, inhalation and others.

End-Users

• Hospitals
• Specialty Clinics
• Others

On the basis of end-users, the mucociliary clearance and dysfunction treatment market is segmented into hospitals, specialty clinics and others. Hospitals dominates the segment in the mucociliary clearance and dysfunction treatment market.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

On the basis of distribution channel, the mucociliary clearance and dysfunction treatment market is segmented into hospital pharmacy, retail pharmacy and others.

Mucociliary Clearance and Dysfunction Treatment Market Regional Analysis/Insights

The mucociliary clearance and dysfunction treatment market is analyzed and market size insights and trends are provided by country, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the mucociliary clearance and dysfunction treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates the mucociliary clearance and dysfunction treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period owing to the increasing prevalence of respiratory diseases and huge investment in research and development in this region.

North America on the other hand is projected to exhibit the highest growth rate during the forecast period due to the presence of advanced of technology and focus of global players on novel technology in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Mucociliary Clearance and Dysfunction Treatment Market Share Analysis

粘液纤毛清除和功能障碍治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对粘液纤毛清除和功能障碍治疗市场的关注有关。

粘膜纤毛清除和功能障碍治疗市场的一些主要参与者包括 VORTRAN Medical Technology 1 Inc.、Smiths Group plc、Monaghan、Hill-Rom Services Inc.、Allergan、Novartis AG、AstraZeneca、Merck KGaA、Regeneron Pharmaceuticals Inc.、Abbott、F. Hoffmann-La Roche Ltd.、Cadila Pharmaceuticals、Eisai Co., Ltd.、Cipla Inc.、Glenmark Pharmaceuticals Limited、Vertical Pharmaceuticals, LLC、TORAY INDUSTRIES, INC. 和 Pfizer Inc. 等。

研究方法：全球粘液纤毛清除和功能障碍治疗市场

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。要了解更多信息，请请求分析师电话或提出您的询问。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域以及供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-mucociliary-clearance-and-dysfunction-treatment-market

SKU-52910